AutoICD API

93690-6

Laboratory

BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal

Definition

Detection of BRAF V600 variants, including V600E (Val600Glu, c.1799T>A) and V600K (Val600Lys, c.1798_1799delGTinsAA), in cell-free DNA. Using cell-free DNA is alternative to invasive tissue biopsies. The most prevalent mutations are V600E (70−90%) and V600K (5−30%); other mutations are rare. A positive result indicates the presence of an activating BRAF mutation and may be useful for guiding the treatment of individuals with melanoma.

LOINC 6-Axis Classification

Component

BRAF gene.p.Val600 mutations

Property

Prid

Time Aspect

Pt

System

Plas.cfDNA

Scale Type

Nom

Method Type

Molgen

Details

Class

MOLPATH.MUT

Order/Observation

Both

Short Name

BRAF p.V600 mutations Plas.cfDNA

Display Name

BRAF gene V600 mutations Molgen Nom (cfDNA)

Related Names

BRAF p.V600 mutationsB-Raf proto-oncogene, serine/threonine kinaseBRAF1B-RAF1Identity or presenceMolecular geneticsMolecular pathologyMOLPATHMOLPATH.MUTATIONSMutMutationMutsNominalNS7P primePCRPlPlasmaPlsmPoint in timeRAFB1Randomv-raf

Frequently Asked Questions

What is LOINC code 93690-6?

LOINC code 93690-6 identifies "BRAF gene V600 mutations [Identifier] in Plasma cell-free DNA by Molecular genetics method Nominal". Detection of BRAF V600 variants, including V600E (Val600Glu, c.1799T>A) and V600K (Val600Lys, c.1798_1799delGTinsAA), in cell-free DNA. Using cell-free DNA is alternative to invasive tissue biopsies. The most prevalent mutations are V600E (70−90%) and V600K (5−30%); other mutations are rare. A positive result indicates the presence of an activating BRAF mutation and may be useful for guiding the treatment of individuals with melanoma.

What does 93690-6 measure?

This code measures BRAF gene.p.Val600 mutations in Plas.cfDNA. It belongs to the MOLPATH.MUT class in the LOINC classification.

What is LOINC?

LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.